Writing for Business Insider, health policy communications thought leader Jove Oliver warns that in addition to the deadly threat of the virus, we face a related threat in the form of the cloud of disinformation and fake news emanating from obscure sources around the Internet. This misinformation can have deadly consequences itself, […]
Dr. Jeff Colyer is back with another piece in the Wall Street Journal providing an update on COVID-19 patients being treated with a combination of the drugs hydroxychloroquine (HC) and azithromycin (more commonly known as Z-Pak). Newly emerging data are showing more potential promise that COVID-19 can be treated with these medicines, with patients […]
The outcome of the world’s response to COVID-19 depends largely on the success of longstanding research and development (R&D) partnerships between public and private sector institutions, including national governments, universities, and pharmaceutical companies. So it’s crucial that governments resist the impulse to undermine these relationships by adopting policies inimical to private sector research […]
“Artificial intelligence in the fight against COVID-19” By Georgios Petropoulos, courtesy of the Bruegel Institute In the face of the coronavirus, digital technologies are vital for both social health and economic performance. A digital response to the COVID-19 pandemic can take multiple forms and bring significant value. One important area in which […]
“Materials Science Revolution Vs. Coronavirus: Copper-Infusion to Turn Common Cotton Fibers Into a ‘Defensive Wall’?” By Sandra Wirtz, courtesy of American Resources Policy Network Last week, we discussed the antimicrobial properties of copper, the re-introduction of which experts argue could help the fight against Coronavirus and future pandemics — particularly in hospitals and other public […]
It’s no exaggeration to say that the fate of the world, or at least the global economy, appears to hang on the possibility of scientists and doctors creating a vaccine for COVID-19 and either producing new drugs or — more realistically for the urgent needs of the present — discovering effective treatments among […]
“Corona crisis – liquidity takes priority” By Prof. Dr. Michael Grömling, Dr. Martin Beznoska, and Dr. Markus Demary, courtesy of IW Koeln In China it became apparent how an epidemic can directly affect the production potential of an economy when large numbers of workers have to be quarantined. Through a variety of intermediate […]
“Europe under siege” By Fabian Zuleeg and Janis Emmanouilidis, courtesy of EPC The European Union (EU) and its member states have been hit hard by COVID-19 – but the worst is yet to come. Tragically, more people will lose their lives. Now, the highest priority for Europe’s healthcare systems must be to do what […]
“Will economic measures against the coronavirus be effective?” By Hugo Pereira, courtesy of Civismo We are, without a doubt, facing a historic moment. The coronavirus not only infected people, but practically all of the social spheres: politics, the economy, and even our own psychology. We have come to realize that we are not as […]
“Temporarily Unshackled Private Sector Responds to Demand for More Coronavirus Tests” By Jeffrey Singer, courtesy of the Cato Institute I and others have attributed much of the initially flat‐footed response of public health officials to the coronavirus pandemic to cumbersome, inflexible, and outdated regulations controlling the development and distribution of drugs and tests. As I pointed […]